An Evidence-Based Global MS Patient Charter Created by a Multi-stakeholder Alliance Wiendl H et al.Poster: 046 Abstract
Remibrutinib Ameliorates CNS Autoimmune Disease - Insights From EAE Cenni B et al.Poster: 042 Abstract
Remibrutinib Inhibits Neuroinflammation Driven by B cells and Myeloid Cells in EAE Nuesslein-Hildesheim B et al.Poster: 043 Abstract
Phase 3 REMODEL I/II Trials: Efficacy, Safety and Tolerability of Remibrutinib in RMS Wiendl H et al.Poster: 044 Abstract
Remibrutinib’s Safety Across Immune-Mediated Diseases Supports Development in MS Montalban X et al.Poster: 047 Abstract